Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Vassilieff
Hematologic Responses to Deferasirox Therapy in Transfusion-Dependent Patients With Myelodysplastic Syndromes
Haematologica
Hematology
Related publications
Impact of Lenalidomide Use Among Non-Transfusion Dependent Patients With Myelodysplastic Syndromes
American Journal of Hematology
Hematology
Deferasirox Therapy Is Associated With Reduced Mortality Risk in a Medicare Population With Myelodysplastic Syndromes
Journal of Comparative Effectiveness Research
Health Policy
Developments in the Treatment of Transfusion-Dependent Anemia in Patients With Myelodysplastic Syndromes: Epidemiology, Etiology, Genetics, and Targeted Therapies
Advances in Genomics and Genetics
Daily Alternating Deferasirox and Deferiprone Therapy Successfully Controls Iron Accumulation in Untreatable Transfusion Dependent Thalassemia Patients
American Journal of Hematology
Hematology
Clonogenic Responses of Selected Cd 34 + Li-Precursors in Stroma Dependent Systems From Patients With Myelodysplastic Syndromes
Pediatric Research
Child Health
Pediatrics
Perinatology
Deferasirox Reduces Oxidative Stress in Patients With Transfusion Dependency
Journal of Clinical Medicine Research
Hematologic Responses in Patients With Aplastic Anemia Treated With Deferasirox: A Post Hoc Analysis From the EPIC Study
Haematologica
Hematology
Cost Effectiveness of Lenalidomide in the Treatment of Transfusion-Dependent Myelodysplastic Syndromes in the United States
Cancer Control
Medicine
Oncology
Hematology
Patients With Sickle Cell Anemia on Simple Chronic Transfusion Protocol Show Sex Differences for Hemodynamic and Hematologic Responses to Transfusion
Transfusion
Allergy
Immunology
Hematology
